Bilateral testicular germ cell tumors

Testicular cancer represents 1% to 1.5% of neoplasias in males and 5% of urologic tumors in general. The incidence of bilateral testicular tumors is 1–5%. Approximately one third of the cases are diagnosed as synchronous, while the other two thirds are diagnosed as metachronous tumors. Additionally,...

Full description

Saved in:
Bibliographic Details
Published in:Turkish journal of urology 2013-12, Vol.39 (4), p.249-252
Main Authors: Sarıcı, Haşmet, Telli, Onur, Eroğlu, Muzaffer
Format: Article
Language:English
Subjects:
Urooncology
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c314t-d2b6cd066f6ff6ea06faac96355bdc1c6b50f7ad290132367a4ed92a3812689f3
cites
container_end_page 252
container_issue 4
container_start_page 249
container_title Turkish journal of urology
container_volume 39
creator Sarıcı, Haşmet
Telli, Onur
Eroğlu, Muzaffer
description Testicular cancer represents 1% to 1.5% of neoplasias in males and 5% of urologic tumors in general. The incidence of bilateral testicular tumors is 1–5%. Approximately one third of the cases are diagnosed as synchronous, while the other two thirds are diagnosed as metachronous tumors. Additionally, 5% of all patients diagnosed with testicular cancer may have contralateral intratubular germ cell neoplasia and may develop a contralateral germ cell tumor. However, few data are available regarding bilateral testicular germ cell tumors (BTGCTs). In this review, we aim to provide an overview of the incidence, pathological features and clinical outcomes.of BTGCTs.
doi_str_mv 10.5152/tud.2013.062
format article
fullrecord <record><control><sourceid>pubmedcentral</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4548607</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_4548607</sourcerecordid><originalsourceid>FETCH-LOGICAL-c314t-d2b6cd066f6ff6ea06faac96355bdc1c6b50f7ad290132367a4ed92a3812689f3</originalsourceid><addsrcrecordid>eNpVjk9LxDAUxIMo7rLuzQ_Qi8fW5CV5bS6CLq4KC170XF7zZw20u0uaCn57C-rB0wwzMPNj7FrwSgsNt3lyFXAhK45wxpYglCkl1_X5nwepF2w9jrHjStUodcMv2QJQQiOEWbKbh9hT9on6IvsxRzv1lIq9T0NhfT-H03BM4xW7CNSPfv2rK_a-fXzbPJe716eXzf2utFKoXDro0DqOGDAE9MQxEFkzv-rOWWGx0zzU5MDMyCCxJuWdAZKNAGxMkCt297N7mrrBO-sPeSZrTykOlL7aI8X2f3OIH-3--NkqrRrktfwGjJJPcA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Bilateral testicular germ cell tumors</title><source>Open Access: PubMed Central</source><creator>Sarıcı, Haşmet ; Telli, Onur ; Eroğlu, Muzaffer</creator><creatorcontrib>Sarıcı, Haşmet ; Telli, Onur ; Eroğlu, Muzaffer</creatorcontrib><description>Testicular cancer represents 1% to 1.5% of neoplasias in males and 5% of urologic tumors in general. The incidence of bilateral testicular tumors is 1–5%. Approximately one third of the cases are diagnosed as synchronous, while the other two thirds are diagnosed as metachronous tumors. Additionally, 5% of all patients diagnosed with testicular cancer may have contralateral intratubular germ cell neoplasia and may develop a contralateral germ cell tumor. However, few data are available regarding bilateral testicular germ cell tumors (BTGCTs). In this review, we aim to provide an overview of the incidence, pathological features and clinical outcomes.of BTGCTs.</description><identifier>ISSN: 2149-3235</identifier><identifier>EISSN: 2149-3057</identifier><identifier>DOI: 10.5152/tud.2013.062</identifier><identifier>PMID: 26328119</identifier><language>eng</language><publisher>Turkish Association of Urology</publisher><subject>Urooncology</subject><ispartof>Turkish journal of urology, 2013-12, Vol.39 (4), p.249-252</ispartof><rights>Copyright 2013 by Turkish Association of Urology 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c314t-d2b6cd066f6ff6ea06faac96355bdc1c6b50f7ad290132367a4ed92a3812689f3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4548607/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4548607/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,315,733,786,790,891,27957,27958,53827,53829</link.rule.ids></links><search><creatorcontrib>Sarıcı, Haşmet</creatorcontrib><creatorcontrib>Telli, Onur</creatorcontrib><creatorcontrib>Eroğlu, Muzaffer</creatorcontrib><title>Bilateral testicular germ cell tumors</title><title>Turkish journal of urology</title><description>Testicular cancer represents 1% to 1.5% of neoplasias in males and 5% of urologic tumors in general. The incidence of bilateral testicular tumors is 1–5%. Approximately one third of the cases are diagnosed as synchronous, while the other two thirds are diagnosed as metachronous tumors. Additionally, 5% of all patients diagnosed with testicular cancer may have contralateral intratubular germ cell neoplasia and may develop a contralateral germ cell tumor. However, few data are available regarding bilateral testicular germ cell tumors (BTGCTs). In this review, we aim to provide an overview of the incidence, pathological features and clinical outcomes.of BTGCTs.</description><subject>Urooncology</subject><issn>2149-3235</issn><issn>2149-3057</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNpVjk9LxDAUxIMo7rLuzQ_Qi8fW5CV5bS6CLq4KC170XF7zZw20u0uaCn57C-rB0wwzMPNj7FrwSgsNt3lyFXAhK45wxpYglCkl1_X5nwepF2w9jrHjStUodcMv2QJQQiOEWbKbh9hT9on6IvsxRzv1lIq9T0NhfT-H03BM4xW7CNSPfv2rK_a-fXzbPJe716eXzf2utFKoXDro0DqOGDAE9MQxEFkzv-rOWWGx0zzU5MDMyCCxJuWdAZKNAGxMkCt297N7mrrBO-sPeSZrTykOlL7aI8X2f3OIH-3--NkqrRrktfwGjJJPcA</recordid><startdate>20131201</startdate><enddate>20131201</enddate><creator>Sarıcı, Haşmet</creator><creator>Telli, Onur</creator><creator>Eroğlu, Muzaffer</creator><general>Turkish Association of Urology</general><scope>5PM</scope></search><sort><creationdate>20131201</creationdate><title>Bilateral testicular germ cell tumors</title><author>Sarıcı, Haşmet ; Telli, Onur ; Eroğlu, Muzaffer</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c314t-d2b6cd066f6ff6ea06faac96355bdc1c6b50f7ad290132367a4ed92a3812689f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Urooncology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sarıcı, Haşmet</creatorcontrib><creatorcontrib>Telli, Onur</creatorcontrib><creatorcontrib>Eroğlu, Muzaffer</creatorcontrib><collection>PubMed Central (Full Participant titles)</collection><jtitle>Turkish journal of urology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sarıcı, Haşmet</au><au>Telli, Onur</au><au>Eroğlu, Muzaffer</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bilateral testicular germ cell tumors</atitle><jtitle>Turkish journal of urology</jtitle><date>2013-12-01</date><risdate>2013</risdate><volume>39</volume><issue>4</issue><spage>249</spage><epage>252</epage><pages>249-252</pages><issn>2149-3235</issn><eissn>2149-3057</eissn><abstract>Testicular cancer represents 1% to 1.5% of neoplasias in males and 5% of urologic tumors in general. The incidence of bilateral testicular tumors is 1–5%. Approximately one third of the cases are diagnosed as synchronous, while the other two thirds are diagnosed as metachronous tumors. Additionally, 5% of all patients diagnosed with testicular cancer may have contralateral intratubular germ cell neoplasia and may develop a contralateral germ cell tumor. However, few data are available regarding bilateral testicular germ cell tumors (BTGCTs). In this review, we aim to provide an overview of the incidence, pathological features and clinical outcomes.of BTGCTs.</abstract><pub>Turkish Association of Urology</pub><pmid>26328119</pmid><doi>10.5152/tud.2013.062</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2149-3235
ispartof Turkish journal of urology, 2013-12, Vol.39 (4), p.249-252
issn 2149-3235
2149-3057
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4548607
source Open Access: PubMed Central
subjects Urooncology
title Bilateral testicular germ cell tumors
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-21T22%3A44%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bilateral%20testicular%20germ%20cell%20tumors&rft.jtitle=Turkish%20journal%20of%20urology&rft.au=Sar%C4%B1c%C4%B1,%20Ha%C5%9Fmet&rft.date=2013-12-01&rft.volume=39&rft.issue=4&rft.spage=249&rft.epage=252&rft.pages=249-252&rft.issn=2149-3235&rft.eissn=2149-3057&rft_id=info:doi/10.5152/tud.2013.062&rft_dat=%3Cpubmedcentral%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_4548607%3C/pubmedcentral%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c314t-d2b6cd066f6ff6ea06faac96355bdc1c6b50f7ad290132367a4ed92a3812689f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/26328119&rfr_iscdi=true